Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Chih-Min Tang, Tracy E. Lee, Sabriya A. Syed, Adam M. Burgoyne, Stephanie Y. Leonard, Fei Gao, Jonathan C. Chan, Eileen Shi, Juliann Chmielecki, Deborah Morosini, Kai Wang, Jeffrey S. Ross, Michael L. Kendrick, Michael R. Bardsley, Martina De Siena, Junhao Mao, Olivier Harismendy, Tamas Ordog, Jason K. Sicklick
Published Oct 25, 2016 · Vol. 7, No. 48 · pp. 78226-78241
Marieke I.G. Raaijmakers, Daniel S. Widmer, Apurva Narechania, Ossia Eichhoff, Sandra N. Freiberger, Judith Wenzina, Phil F. Cheng, Daniela Mihic-Probst, Rob Desalle, Reinhard Dummer, Mitchell P. Levesque
Published Oct 24, 2016 · Vol. 7, No. 47 · pp. 77163-77174
Alexandre Chlenski, Marija Dobratic, Helen R. Salwen, Mark Applebaum, Lisa J. Guerrero, Ryan Miller, Gillian DeWane, Elena Solomaha, Jeremy D. Marks, Susan L. Cohn
Published Oct 20, 2016 · Vol. 7, No. 47 · pp. 77696-77706